LEUCOGEN

Clinical trials for LEUCOGEN explained in plain language.

Never miss a new study

Get alerted when new LEUCOGEN trials appear

Sign up with your email to follow new studies for LEUCOGEN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug may protect breast cancer patients from dangerous infection risk

Disease control Recruiting now

This study tests whether a drug called leucogen can prevent severe neutropenia (dangerously low white blood cell counts) in women with early-stage hormone receptor-positive, HER2-negative breast cancer who are receiving ribociclib plus hormone therapy. About 94 participants will …

Matched conditions: LEUCOGEN

Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated May 26, 2026 09:48 UTC

LEUCOGEN

Get alerted when new LEUCOGEN trials appear

New drug may protect breast cancer patients from dangerous infection risk